Search Results - "Maki, Carl G." :: K.UTB vyhledávací portál

Loading…

Pharmacologic activation of p53 by small-molecule MDM2 antagonists

by Shen, Hong, Maki, Carl G
Published in Current pharmaceutical design (01.02.2011)

Get more information

Journal Article

Loading…

CSE1L is a negative regulator of the RB-DREAM pathway in p53 wild-type NSCLC and can be targeted using an HDAC1/2 inhibitor

by Duan, Lei, Tadi, Mehrdad Jafari, Maki, Carl G.
Published in Scientific reports (27.09.2023)

Get full text

Journal Article

Loading…

RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC

by Duan, Lei, Perez, Ricardo E., Calhoun, Sarah, Maki, Carl G.
Published in Scientific reports (20.01.2022)

Get full text

Journal Article

Loading…

Acetyl-CoA synthetases ACSS1 and ACSS2 are 4-hydroxytamoxifen responsive factors that promote survival in tamoxifen treated and estrogen deprived cells

by Calhoun, Sarah, Duan, Lei, Maki, Carl G.
Published in Translational oncology (01.05.2022)

Get full text

Journal Article

Loading…

Author Correction: RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC

by Duan, Lei, Perez, Ricardo E., Calhoun, Sarah, Maki, Carl G.
Published in Scientific reports (16.03.2022)

Get full text

Journal Article

Loading…

Novel roles for p53 in the genesis and targeting of tetraploid cancer cells

by Davaadelger, Batzaya, Shen, Hong, Maki, Carl G
Published in PloS one (07.11.2014)

Get full text

Journal Article

Loading…

Prolylcarboxypeptidase promotes IGF1R/HER3 signaling and is a potential target to improve endocrine therapy response in estrogen receptor positive breast cancer

by Duan, Lei, Calhoun, Sarah J., Perez, Ricardo E., Macias, Virgilia, Mir, Fatima, Gattuso, Paolo, Maki, Carl G.
Published in Cancer biology & therapy (31.12.2022)

Get full text

Journal Article

Loading…

Regulation of p53 Nuclear Export through Sequential Changes in Conformation and Ubiquitination

by Nie, Linghu, Sasaki, Mark, Maki, Carl G.
Published in The Journal of biological chemistry (11.05.2007)

Get full text

Journal Article

Loading…

The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis

by Davaadelger, Batzaya, Perez, Ricardo E., Zhou, Yalu, Duan, Lei, Gitelis, Steven, Maki, Carl G.
Published in Cancer biology & therapy (02.11.2017)

Get full text

Journal Article

Loading…

Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor

by Davaadelger, Batzaya, Duan, Lei, Perez, Ricardo E, Gitelis, Steven, Maki, Carl G
Published in Oncotarget (10.05.2016)

Get full text

Journal Article

Loading…

Transient nutlin-3a treatment promotes endoreduplication and the generation of therapy-resistant tetraploid cells

by Shen, Hong, Moran, Diarmuid M, Maki, Carl G
Published in Cancer research (Chicago, Ill.) (15.10.2008)

Get full text

Journal Article

Loading…

Two 4N cell-cycle arrests contribute to cisplatin-resistance

by Shen, Hong, Perez, Ricardo E, Davaadelger, Batzaya, Maki, Carl G
Published in PloS one (01.04.2013)

Get full text

Journal Article

Loading…

MDM2 Binding Induces a Conformational Change in p53 That Is Opposed by Heat-shock Protein 90 and Precedes p53 Proteasomal Degradation

by Sasaki, Mark, Nie, Linghu, Maki, Carl G.
Published in The Journal of biological chemistry (11.05.2007)

Get full text

Journal Article

Loading…

The Prolyl Peptidases PRCP/PREP Regulate IRS-1 Stability Critical for Rapamycin-induced Feedback Activation of PI3K and AKT

by Duan, Lei, Ying, Guoguang, Danzer, Brian, Perez, Ricardo E., Shariat-Madar, Zia, Levenson, Victor V., Maki, Carl G.
Published in The Journal of biological chemistry (01.08.2014)

Get full text

Journal Article